These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15678646)

  • 1. Atypical neuroleptic malignant syndrome presenting as fever of unknown origin in the elderly.
    Hall RC; Appleby B; Hall RC
    South Med J; 2005 Jan; 98(1):114-7. PubMed ID: 15678646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olanzapine-associated neuroleptic malignant syndrome.
    Norgard NB; Stark JE
    Pharmacotherapy; 2006 Aug; 26(8):1180-2. PubMed ID: 16863495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuroleptic malignant syndrome : Rare cause of fever of unknown origin].
    Chackupurakal R; Wild U; Kamm M; Wappler F; Reske D; Sakka SG
    Anaesthesist; 2015 Jul; 64(7):527-31. PubMed ID: 26122200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zuclopenthixol-induced neuroleptic malignant syndrome presenting as fever of unknown origin, hyperglycaemia and acute myocardial infarction in a 60-year-old man.
    Varoglu AO; Ates O; Gundogdu OL; Aksoy A; Deniz O
    World J Biol Psychiatry; 2009; 10(4 Pt 2):644-7. PubMed ID: 17965986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olanzapine-associated neuroleptic malignant syndrome in a patient receiving concomitant rivastigmine therapy.
    Stevens DL; Lee MR; Padua Y
    Pharmacotherapy; 2008 Mar; 28(3):403-5. PubMed ID: 18294120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptic malignant syndrome associated with the use of prochlorperazine in a patient with a recent history of antipsychotic-induced neuroleptic malignant syndrome.
    Musselman ME; Browning LA; Parker D; Saely S
    Ann Pharmacother; 2011 Nov; 45(11):e61. PubMed ID: 21972252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypicality in presentation of neuroleptic malignant syndrome caused by olanzapine.
    Mishra B; Mishra B; Sahoo S; Arora M; Khess CR
    Indian J Med Sci; 2007 Oct; 61(10):570-3. PubMed ID: 17932448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic malignant syndrome due to olanzapine.
    Hall KL; Taylor WH; Ware MR
    Psychopharmacol Bull; 2001; 35(3):49-54. PubMed ID: 12397878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olanzapine-induced neuroleptic malignant syndrome in a patient with paranoid schizophrenia.
    Srivastava A; Borkar HA; Chandak S
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):119-21. PubMed ID: 19067992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic malignant syndrome associated with olanzapine.
    Johnson V; Bruxner G
    Aust N Z J Psychiatry; 1998 Dec; 32(6):884-6. PubMed ID: 10084355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical neuroleptic malignant syndrome: diagnostic controversies and considerations.
    Picard LS; Lindsay S; Strawn JR; Kaneria RM; Patel NC; Keck PE
    Pharmacotherapy; 2008 Apr; 28(4):530-5. PubMed ID: 18363536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuroleptic malignant syndrome: case report with recurrence associated with the use of olanzapine].
    Hanel RA; Sandmann MC; Kranich M; De Bittencourt PR
    Arq Neuropsiquiatr; 1998 Dec; 56(4):833-7. PubMed ID: 10029891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuroleptic malignant syndrome after treatment with olanzapine].
    Emborg C
    Ugeskr Laeger; 1999 Mar; 161(10):1424-5. PubMed ID: 10085753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical neuroleptic malignant syndrome caused by olanzapine.
    Nielsen J; Bruhn AM
    Acta Psychiatr Scand; 2005 Sep; 112(3):238-40; discussion 240. PubMed ID: 16095481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic-induced catatonia: clinical presentation, response to benzodiazepines, and relationship to neuroleptic malignant syndrome.
    Lee JW
    J Clin Psychopharmacol; 2010 Feb; 30(1):3-10. PubMed ID: 20075641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic malignant syndrome in an adolescent receiving olanzapine-lithium combination therapy.
    Berry N; Pradhan S; Sagar R; Gupta SK
    Pharmacotherapy; 2003 Feb; 23(2):255-9. PubMed ID: 12587815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical neuroleptic malignant syndrome associated with olanzapine.
    Reeves RR; Torres RA; Liberto V; Hart RH
    Pharmacotherapy; 2002 May; 22(5):641-4. PubMed ID: 12013364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinguishing neuroleptic malignant syndrome (NMS) from NMS-like acute medical illnesses: a study of 34 cases.
    Sewell DD; Jeste DV
    J Neuropsychiatry Clin Neurosci; 1992; 4(3):265-9. PubMed ID: 1354002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Series of seizures as a sign of development of recurrent malignant neuroleptic syndrome - a case report.
    Supe S; Matijević V; Kondić L; Alvir D
    Psychiatr Danub; 2006 Jun; 18(1-2):97-101. PubMed ID: 16804507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.